Front | Back |
Vmax
|
Max rate of reaction for given amt of enz; proportional to [enz[
|
Km
|
Michaelis constant; [substrate] reqd to reach V50; inversely proportional to affinity (ie high Km=more substrate reqd to reach same rate=lower affinity of enz for substrate)
|
Michaelis Menton plot
|
Y axis=V, X axis=[S] |
Lineweaver Burke plot
|
Y axis=1/V, X axis=1/Km; Y intercept=1/Vmax, X intercept= -1/Km |
Competitive vs Non-competitive inhibitors
|
Competitive=bind active site, similar to substrate, CAN overcome inhibition with higher [S], increases Km/decreases potency, same Vmax/efficacy
Non=bind allosteric site OR active site irreversibly, CANNOT overcome inhibition, decreases Vmax/efficacy, same Km/potency |
Vd
|
Volume of distribution=total body amount of drug(mass)/plasma concentration of drug(mass/volume)
4-8L=blood, 12-14L=ECF, >TBW ~40L=fat, etc **altered in hepatic/renal failure=decrease plasma proteins (dec synth/inc excr) which bind drugs and hold in vasculature |
Cl
|
Clearance=elimination rate (mass/time)/plasma drug concentration (mass/volume)=(volume/time)
=Ke*Vd renal=GFR*free fraction of drug (unbound) |
T1/2
|
Half life=0.7*Vd/Cl
refers to decrease with elimination or increase with infusion 4-5* t1/2=t to achieve steady state (93.75-96.9%) |
Loading vs maintenance dose
|
LD=Vd*plasma concentration/F
MD=Cl*plasma concentration/F F=Bioavailability, IV=1 |
Drug elimination kinetics
|
Zero order=constant AMOUNT/time ex Peas and WHEATS: Phenytoin/Phenylbutazone, Warfarin, Heparin, Ethanol, Aspirin, Theophylline/Tobutamide, Salicylates First order=constant FRACTION/time ex most drugs |
Biotransformation
|
In liver; lipid soluble drugs->water sol for excr
Phase I Cyp450-SER; reqs O2, NADP, ox/red NonCYP450-MAO, hydrolysis Phase II Conjugation of func groups to nonpolar for excr, transferases |
Graded dose response curves
|
Remember: parallel=can compare potency AND efficacy perpendicular=can only compare efficacy; potency dept on dose |
CYP450 inhibitors
|
Recall: to metabolize lipid soluble drugs to water soluble metabolites for excretion so: induce=more excretion=lower Cp=higher dose needed inhibit=less excretion=toxic accumulation=lower dose needed |
TI
|
Therapeutic Index=safety margin =median toxic/lethal dose/median therapeutic/effective dose =LD50/ED50 |
NN
NM |
Autonomic nicotinic Ach Rs=ligand gated Na+/K+ channels; parasymp and symp postganglionic neurons
somatic muscular nAchRs at neuromuscular jxn (motor neuron direct to) |